Why the study?
Does the addition of quinidine to digoxin therapy increase serum digoxin concentrations?
Does the addition of quinidine to digoxin therapy increase serum digoxin concentrations?
Co-administration of quinidine and digoxin significantly increases serum digoxin levels by reducing renal clearance, necessitating a 30-50% reduction in digoxin dose to prevent toxicity.
Answers are grounded in this paper and cite their sources.
Quinidine co-administration was associated with higher digoxin exposure; supports monitoring but should not yet change practice without RCTs.
Administration of quinidine with digoxin increased serum digoxin concentrations in 79 patients and five volunteers. In 38 patients on a constant glycoside maintenance dose, the addition of quinidine to digoxin therapy resulted in a mean 2.5-fold increase (from 0.98 +/- 0.37 to 2.47 +/- 0.71 ng per milliliter, mean +/- 1 S.D.) (P less than 0.001). The addition of quinidine decreased renal glycoside clearance (from 91.6 +/- 27.8 to 40.6 +/- 15.8 ml per minute) (P less than 0.001). Unlike other investigations, our studies provided no evidence that quinidine displaced digoxin at specific cardiac binding sites. The elevated digoxin levels found during quinidine administration suggest a 30 to 50 per cent reduction of the digoxin dose. Adverse reactions to combined quinidine-digoxin therapy may be partly due to digitalis intoxication.
No takes yet. Share an insight, caveat, or question.
W. Doering (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: